Here are what the editors at HealthDay consider to be the most important developments in Critical Care for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Infective Endocarditis Related to Injection Drug Use Rising
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The risk for infective endocarditis related to injection drug use increased from 2006 to 2015, according to a study published online Jan. 28 in CMAJ, the journal of the Canadian Medical Association.
NOACs Recommended as First-Line Prevention of Stroke in A-Fib
TUESDAY, Jan. 29, 2019 (HealthDay News) — For patients with atrial fibrillation, novel oral anticoagulants (NOACs) are recommended over warfarin to prevent stroke and weight loss is recommended for overweight and obese individuals, according to updated guidelines published online Jan. 28 in Circulation.
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
Gun Injury Hospitalization Cost Over $911 Million 2010 to 2015
THURSDAY, Jan. 24, 2019 (HealthDay News) — The average annual cost of inpatient hospitalizations for firearm injury exceeded $911 million from 2010 to 2015, with 9.5 percent of that amount due to readmissions, according to a study published online Jan. 24 in PLOS ONE.
Doctors Should Encourage Exercise in Patients With Diabetes, CV Disease
WEDNESDAY, Jan. 23, 2019 (HealthDay News) — Physicians need to take an active role in prescribing specific exercise training in patients with both type 2 diabetes mellitus and cardiovascular disease, according to a position paper published online Jan. 14 in the European Journal of Preventive Cardiology.
FDA Down to 5 Weeks of Funding to Review New Drug Applications
THURSDAY, Jan. 17, 2019 (HealthDay News) — Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.
Adoption of Advanced Health IT Capabilities Inconsistent
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.